APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Plasma Fractionation

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Blood Plasma Fractionation Market Outlook and Growth Opportunities 2026

19 December 2025201 pages

Choose your research edition.

Industry ResearchBlood Plasma Fractionation Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Plasma Fractionation Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Blood Plasma Fractionation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Plasma Fractionation Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Plasma Fractionation Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Blood Plasma Fractionation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Blood Plasma Fractionation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood Plasma Fractionation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Plasma Fractionation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Blood Plasma Fractionation market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Blood Plasma Fractionation market include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Blood Plasma Fractionation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood Plasma Fractionation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Plasma Fractionation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Blood Plasma Fractionation market size, projected growth trends, production technologies, key applications, and end-use industries.

Blood Plasma Fractionation Segment by Company

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Tiantan Bio

Shuanglin Bio

Boya Bio

Yuanda Shuyang

Weiguang Bio

Nanyue Bio

KM Biologics

Blood Plasma Fractionation Segment by Type

Immune Globulin

Coagulation Factor

Albumin

Others

Blood Plasma Fractionation Segment by Application

Hospital

Retail Pharmacy

Others

Blood Plasma Fractionation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Blood Plasma Fractionation status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Blood Plasma Fractionation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Blood Plasma Fractionation significant trends, drivers, influence factors in global and regions.

6. To analyze Blood Plasma Fractionation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Plasma Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma Fractionation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Blood Plasma Fractionation market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Plasma Fractionation industry.

Chapter 3: Detailed analysis of Blood Plasma Fractionation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Blood Plasma Fractionation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Blood Plasma Fractionation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Blood Plasma Fractionation Industry Trends Table 2. Blood Plasma Fractionation Industry Drivers Table 3. Blood Plasma Fractionation Industry Opportunities and Challenges Table 4. Blood Plasma Fractionation Industry Restraints Table 5. Global Blood Plasma Fractionation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Blood Plasma Fractionation Revenue Share by Company (2021-2026) Table 7. Global Blood Plasma Fractionation Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Blood Plasma Fractionation Sales Volume Share by Company (2021-2026) Table 9. Global Blood Plasma Fractionation Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Blood Plasma Fractionation Company Ranking, (2024-2026) & (USD Million) Table 11. Global Blood Plasma Fractionation Key Company Manufacturing Base & Headquarters Table 12. Global Blood Plasma Fractionation Company, Product Type & Application Table 13. Global Blood Plasma Fractionation Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Blood Plasma Fractionation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Immune Globulin Table 18. Significant Companies of Coagulation Factor Table 19. Significant Companies of Albumin Table 20. Significant Companies of Others Table 21. Global Blood Plasma Fractionation Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Blood Plasma Fractionation Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Blood Plasma Fractionation Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Blood Plasma Fractionation Sales Volume Share by Type (2021-2026) Table 25. Global Blood Plasma Fractionation Sales Volume Share by Type (2027-2032) Table 26. Global Blood Plasma Fractionation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Blood Plasma Fractionation Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Blood Plasma Fractionation Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Blood Plasma Fractionation Sales Value Share by Type (2021-2026) Table 30. Global Blood Plasma Fractionation Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Retail Pharmacy Table 33. Significant Companies of Others Table 34. Global Blood Plasma Fractionation Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Blood Plasma Fractionation Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Blood Plasma Fractionation Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Blood Plasma Fractionation Sales Volume Share by Application (2021-2026) Table 38. Global Blood Plasma Fractionation Sales Volume Share by Application (2027-2032) Table 39. Global Blood Plasma Fractionation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Blood Plasma Fractionation Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Blood Plasma Fractionation Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Blood Plasma Fractionation Sales Value Share by Application (2021-2026) Table 43. Global Blood Plasma Fractionation Sales Value Share by Application (2027-2032) Table 44. Global Blood Plasma Fractionation Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Blood Plasma Fractionation Sales by Region (2021-2026) & (K Units) Table 46. Global Blood Plasma Fractionation Sales Market Share by Region (2021-2026) Table 47. Global Blood Plasma Fractionation Sales by Region (2027-2032) & (K Units) Table 48. Global Blood Plasma Fractionation Sales Market Share by Region (2027-2032) Table 49. Global Blood Plasma Fractionation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Blood Plasma Fractionation Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Blood Plasma Fractionation Sales Value Share by Region (2021-2026) Table 52. Global Blood Plasma Fractionation Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Blood Plasma Fractionation Sales Value Share by Region (2027-2032) Table 54. Global Blood Plasma Fractionation Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Blood Plasma Fractionation Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Blood Plasma Fractionation Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Blood Plasma Fractionation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Blood Plasma Fractionation Sales by Country (2021-2026) & (K Units) Table 59. Global Blood Plasma Fractionation Sales Market Share by Country (2021-2026) Table 60. Global Blood Plasma Fractionation Sales by Country (2027-2032) & (K Units) Table 61. Global Blood Plasma Fractionation Sales Market Share by Country (2027-2032) Table 62. Global Blood Plasma Fractionation Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Blood Plasma Fractionation Sales Value Market Share by Country (2021-2026) Table 64. Global Blood Plasma Fractionation Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Blood Plasma Fractionation Sales Value Market Share by Country (2027-2032) Table 66. Takeda Company Information Table 67. Takeda Business Overview Table 68. Takeda Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Takeda Blood Plasma Fractionation Product Portfolio Table 70. Takeda Recent Development Table 71. CSL Company Information Table 72. CSL Business Overview Table 73. CSL Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. CSL Blood Plasma Fractionation Product Portfolio Table 75. CSL Recent Development Table 76. Grifols Company Information Table 77. Grifols Business Overview Table 78. Grifols Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Grifols Blood Plasma Fractionation Product Portfolio Table 80. Grifols Recent Development Table 81. Octapharma Company Information Table 82. Octapharma Business Overview Table 83. Octapharma Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Octapharma Blood Plasma Fractionation Product Portfolio Table 85. Octapharma Recent Development Table 86. Kedrion Company Information Table 87. Kedrion Business Overview Table 88. Kedrion Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Kedrion Blood Plasma Fractionation Product Portfolio Table 90. Kedrion Recent Development Table 91. LFB Group Company Information Table 92. LFB Group Business Overview Table 93. LFB Group Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. LFB Group Blood Plasma Fractionation Product Portfolio Table 95. LFB Group Recent Development Table 96. Biotest Company Information Table 97. Biotest Business Overview Table 98. Biotest Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Biotest Blood Plasma Fractionation Product Portfolio Table 100. Biotest Recent Development Table 101. BPL Company Information Table 102. BPL Business Overview Table 103. BPL Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. BPL Blood Plasma Fractionation Product Portfolio Table 105. BPL Recent Development Table 106. RAAS Company Information Table 107. RAAS Business Overview Table 108. RAAS Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. RAAS Blood Plasma Fractionation Product Portfolio Table 110. RAAS Recent Development Table 111. CBPO Company Information Table 112. CBPO Business Overview Table 113. CBPO Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. CBPO Blood Plasma Fractionation Product Portfolio Table 115. CBPO Recent Development Table 116. Hualan Bio Company Information Table 117. Hualan Bio Business Overview Table 118. Hualan Bio Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Hualan Bio Blood Plasma Fractionation Product Portfolio Table 120. Hualan Bio Recent Development Table 121. Tiantan Bio Company Information Table 122. Tiantan Bio Business Overview Table 123. Tiantan Bio Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Tiantan Bio Blood Plasma Fractionation Product Portfolio Table 125. Tiantan Bio Recent Development Table 126. Shuanglin Bio Company Information Table 127. Shuanglin Bio Business Overview Table 128. Shuanglin Bio Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Shuanglin Bio Blood Plasma Fractionation Product Portfolio Table 130. Shuanglin Bio Recent Development Table 131. Boya Bio Company Information Table 132. Boya Bio Business Overview Table 133. Boya Bio Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Boya Bio Blood Plasma Fractionation Product Portfolio Table 135. Boya Bio Recent Development Table 136. Yuanda Shuyang Company Information Table 137. Yuanda Shuyang Business Overview Table 138. Yuanda Shuyang Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Yuanda Shuyang Blood Plasma Fractionation Product Portfolio Table 140. Yuanda Shuyang Recent Development Table 141. Weiguang Bio Company Information Table 142. Weiguang Bio Business Overview Table 143. Weiguang Bio Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Weiguang Bio Blood Plasma Fractionation Product Portfolio Table 145. Weiguang Bio Recent Development Table 146. Nanyue Bio Company Information Table 147. Nanyue Bio Business Overview Table 148. Nanyue Bio Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Nanyue Bio Blood Plasma Fractionation Product Portfolio Table 150. Nanyue Bio Recent Development Table 151. KM Biologics Company Information Table 152. KM Biologics Business Overview Table 153. KM Biologics Blood Plasma Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. KM Biologics Blood Plasma Fractionation Product Portfolio Table 155. KM Biologics Recent Development Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Blood Plasma Fractionation Distributors List Table 159. Blood Plasma Fractionation Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Blood Plasma Fractionation Product Image Figure 2. Global Blood Plasma Fractionation Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Plasma Fractionation Sales Value (2021-2032) & (US$ Million) Figure 4. Global Blood Plasma Fractionation Sales (2021-2032) & (K Units) Figure 5. Global Blood Plasma Fractionation Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Blood Plasma Fractionation Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Immune Globulin Image Figure 10. Coagulation Factor Image Figure 11. Albumin Image Figure 12. Others Image Figure 13. Global Blood Plasma Fractionation Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Blood Plasma Fractionation Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Blood Plasma Fractionation Sales Volume Share by Type (2021-2032) Figure 16. Global Blood Plasma Fractionation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Blood Plasma Fractionation Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Blood Plasma Fractionation Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Retail Pharmacy Image Figure 21. Others Image Figure 22. Global Blood Plasma Fractionation Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Blood Plasma Fractionation Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Blood Plasma Fractionation Sales Volume Share by Application (2021-2032) Figure 25. Global Blood Plasma Fractionation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Blood Plasma Fractionation Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Blood Plasma Fractionation Sales Value Share by Application (2021-2032) Figure 28. Global Blood Plasma Fractionation Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Blood Plasma Fractionation Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Blood Plasma Fractionation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Blood Plasma Fractionation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Blood Plasma Fractionation Sales Value (2021-2032) & (US$ Million) Figure 33. North America Blood Plasma Fractionation Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Blood Plasma Fractionation Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Blood Plasma Fractionation Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Blood Plasma Fractionation Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Blood Plasma Fractionation Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Blood Plasma Fractionation Sales Value (2021-2032) & (US$ Million) Figure 39. South America Blood Plasma Fractionation Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Blood Plasma Fractionation Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Blood Plasma Fractionation Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Blood Plasma Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Blood Plasma Fractionation Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Blood Plasma Fractionation Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Immune Globulin
  • Coagulation Factor
  • Albumin
  • Others
Applications
  • Hospital
  • Retail Pharmacy
  • Others
Companies covered
  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Boya Bio
  • Yuanda Shuyang
  • Weiguang Bio
  • Nanyue Bio
  • KM Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Blood Plasma Fractionation Sales Value (2021-2032)
  4. 1.2.2 Global Blood Plasma Fractionation Sales Volume (2021-2032)
  5. 1.2.3 Global Blood Plasma Fractionation Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Blood Plasma Fractionation Market Dynamics
  1. 2.1 Blood Plasma Fractionation Industry Trends
  2. 2.2 Blood Plasma Fractionation Industry Drivers
  3. 2.3 Blood Plasma Fractionation Industry Opportunities and Challenges
  4. 2.4 Blood Plasma Fractionation Industry Restraints
3 Blood Plasma Fractionation Market by Company
  1. 3.1 Global Blood Plasma Fractionation Company Revenue Ranking in 2025
  2. 3.2 Global Blood Plasma Fractionation Revenue by Company (2021-2026)
  3. 3.3 Global Blood Plasma Fractionation Sales Volume by Company (2021-2026)
  4. 3.4 Global Blood Plasma Fractionation Average Price by Company (2021-2026)
  5. 3.5 Global Blood Plasma Fractionation Company Ranking (2024-2026)
  6. 3.6 Global Blood Plasma Fractionation Company Manufacturing Base and Headquarters
  7. 3.7 Global Blood Plasma Fractionation Company Product Type and Application
  8. 3.8 Global Blood Plasma Fractionation Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Blood Plasma Fractionation Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Blood Plasma Fractionation Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Blood Plasma Fractionation Market by Type
  1. 4.1 Blood Plasma Fractionation Type Introduction
  2. 4.1.1 Immune Globulin
  3. 4.1.2 Coagulation Factor
  4. 4.1.3 Albumin
  5. 4.1.4 Others
  6. 4.2 Global Blood Plasma Fractionation Sales Volume by Type
  7. 4.2.1 Global Blood Plasma Fractionation Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Blood Plasma Fractionation Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Blood Plasma Fractionation Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Blood Plasma Fractionation Sales Value by Type
  11. 4.3.1 Global Blood Plasma Fractionation Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Blood Plasma Fractionation Sales Value by Type (2021-2032)
  13. 4.3.3 Global Blood Plasma Fractionation Sales Value Share by Type (2021-2032)
5 Blood Plasma Fractionation Market by Application
  1. 5.1 Blood Plasma Fractionation Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Blood Plasma Fractionation Sales Volume by Application
  6. 5.2.1 Global Blood Plasma Fractionation Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blood Plasma Fractionation Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Blood Plasma Fractionation Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Blood Plasma Fractionation Sales Value by Application
  10. 5.3.1 Global Blood Plasma Fractionation Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Blood Plasma Fractionation Sales Value by Application (2021-2032)
  12. 5.3.3 Global Blood Plasma Fractionation Sales Value Share by Application (2021-2032)
6 Blood Plasma Fractionation Regional Sales and Value Analysis
  1. 6.1 Global Blood Plasma Fractionation Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood Plasma Fractionation Sales by Region (2021-2032)
  3. 6.2.1 Global Blood Plasma Fractionation Sales by Region: 2021-2026
  4. 6.2.2 Global Blood Plasma Fractionation Sales by Region (2027-2032)
  5. 6.3 Global Blood Plasma Fractionation Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Blood Plasma Fractionation Sales Value by Region (2021-2032)
  7. 6.4.1 Global Blood Plasma Fractionation Sales Value by Region: 2021-2026
  8. 6.4.2 Global Blood Plasma Fractionation Sales Value by Region (2027-2032)
  9. 6.5 Global Blood Plasma Fractionation Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Blood Plasma Fractionation Sales Value (2021-2032)
  12. 6.6.2 North America Blood Plasma Fractionation Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Blood Plasma Fractionation Sales Value (2021-2032)
  15. 6.7.2 Europe Blood Plasma Fractionation Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Blood Plasma Fractionation Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Blood Plasma Fractionation Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Blood Plasma Fractionation Sales Value (2021-2032)
  21. 6.9.2 South America Blood Plasma Fractionation Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Blood Plasma Fractionation Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Blood Plasma Fractionation Sales Value Share by Country, 2025 VS 2032
7 Blood Plasma Fractionation Country-level Sales and Value Analysis
  1. 7.1 Global Blood Plasma Fractionation Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Blood Plasma Fractionation Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Blood Plasma Fractionation Sales by Country (2021-2032)
  4. 7.3.1 Global Blood Plasma Fractionation Sales by Country (2021-2026)
  5. 7.3.2 Global Blood Plasma Fractionation Sales by Country (2027-2032)
  6. 7.4 Global Blood Plasma Fractionation Sales Value by Country (2021-2032)
  7. 7.4.1 Global Blood Plasma Fractionation Sales Value by Country (2021-2026)
  8. 7.4.2 Global Blood Plasma Fractionation Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Blood Plasma Fractionation Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Blood Plasma Fractionation Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Blood Plasma Fractionation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Blood Plasma Fractionation Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 CSL
  8. 8.2.1 CSL Company Information
  9. 8.2.2 CSL Business Overview
  10. 8.2.3 CSL Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CSL Blood Plasma Fractionation Product Portfolio
  12. 8.2.5 CSL Recent Developments
  13. 8.3 Grifols
  14. 8.3.1 Grifols Company Information
  15. 8.3.2 Grifols Business Overview
  16. 8.3.3 Grifols Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Grifols Blood Plasma Fractionation Product Portfolio
  18. 8.3.5 Grifols Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Blood Plasma Fractionation Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Kedrion
  26. 8.5.1 Kedrion Company Information
  27. 8.5.2 Kedrion Business Overview
  28. 8.5.3 Kedrion Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kedrion Blood Plasma Fractionation Product Portfolio
  30. 8.5.5 Kedrion Recent Developments
  31. 8.6 LFB Group
  32. 8.6.1 LFB Group Company Information
  33. 8.6.2 LFB Group Business Overview
  34. 8.6.3 LFB Group Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 LFB Group Blood Plasma Fractionation Product Portfolio
  36. 8.6.5 LFB Group Recent Developments
  37. 8.7 Biotest
  38. 8.7.1 Biotest Company Information
  39. 8.7.2 Biotest Business Overview
  40. 8.7.3 Biotest Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Biotest Blood Plasma Fractionation Product Portfolio
  42. 8.7.5 Biotest Recent Developments
  43. 8.8 BPL
  44. 8.8.1 BPL Company Information
  45. 8.8.2 BPL Business Overview
  46. 8.8.3 BPL Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BPL Blood Plasma Fractionation Product Portfolio
  48. 8.8.5 BPL Recent Developments
  49. 8.9 RAAS
  50. 8.9.1 RAAS Company Information
  51. 8.9.2 RAAS Business Overview
  52. 8.9.3 RAAS Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 RAAS Blood Plasma Fractionation Product Portfolio
  54. 8.9.5 RAAS Recent Developments
  55. 8.10 CBPO
  56. 8.10.1 CBPO Company Information
  57. 8.10.2 CBPO Business Overview
  58. 8.10.3 CBPO Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 CBPO Blood Plasma Fractionation Product Portfolio
  60. 8.10.5 CBPO Recent Developments
  61. 8.11 Hualan Bio
  62. 8.11.1 Hualan Bio Company Information
  63. 8.11.2 Hualan Bio Business Overview
  64. 8.11.3 Hualan Bio Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hualan Bio Blood Plasma Fractionation Product Portfolio
  66. 8.11.5 Hualan Bio Recent Developments
  67. 8.12 Tiantan Bio
  68. 8.12.1 Tiantan Bio Company Information
  69. 8.12.2 Tiantan Bio Business Overview
  70. 8.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Tiantan Bio Blood Plasma Fractionation Product Portfolio
  72. 8.12.5 Tiantan Bio Recent Developments
  73. 8.13 Shuanglin Bio
  74. 8.13.1 Shuanglin Bio Company Information
  75. 8.13.2 Shuanglin Bio Business Overview
  76. 8.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Shuanglin Bio Blood Plasma Fractionation Product Portfolio
  78. 8.13.5 Shuanglin Bio Recent Developments
  79. 8.14 Boya Bio
  80. 8.14.1 Boya Bio Company Information
  81. 8.14.2 Boya Bio Business Overview
  82. 8.14.3 Boya Bio Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Boya Bio Blood Plasma Fractionation Product Portfolio
  84. 8.14.5 Boya Bio Recent Developments
  85. 8.15 Yuanda Shuyang
  86. 8.15.1 Yuanda Shuyang Company Information
  87. 8.15.2 Yuanda Shuyang Business Overview
  88. 8.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Yuanda Shuyang Blood Plasma Fractionation Product Portfolio
  90. 8.15.5 Yuanda Shuyang Recent Developments
  91. 8.16 Weiguang Bio
  92. 8.16.1 Weiguang Bio Company Information
  93. 8.16.2 Weiguang Bio Business Overview
  94. 8.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Weiguang Bio Blood Plasma Fractionation Product Portfolio
  96. 8.16.5 Weiguang Bio Recent Developments
  97. 8.17 Nanyue Bio
  98. 8.17.1 Nanyue Bio Company Information
  99. 8.17.2 Nanyue Bio Business Overview
  100. 8.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Nanyue Bio Blood Plasma Fractionation Product Portfolio
  102. 8.17.5 Nanyue Bio Recent Developments
  103. 8.18 KM Biologics
  104. 8.18.1 KM Biologics Company Information
  105. 8.18.2 KM Biologics Business Overview
  106. 8.18.3 KM Biologics Blood Plasma Fractionation Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 KM Biologics Blood Plasma Fractionation Product Portfolio
  108. 8.18.5 KM Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Blood Plasma Fractionation Value Chain Analysis
  2. 9.1.1 Blood Plasma Fractionation Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Blood Plasma Fractionation Sales Mode & Process
  6. 9.2 Blood Plasma Fractionation Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Blood Plasma Fractionation Distributors
  9. 9.2.3 Blood Plasma Fractionation Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst